# Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

> **NCT04474483** · PHASE2 · TERMINATED · sponsor: **State University of New York at Buffalo** · enrollment: 8 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Melatonin
- **OTHER:** Placebo (Methylcellulose) capsule

## Key facts

- **NCT ID:** NCT04474483
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-06
- **Primary completion:** 2022-07-22
- **Final completion:** 2022-07-22
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** difficult recruitment and complete first visit in person during thne hight of tne pandemic and later not enough subjects
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04474483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04474483, "Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04474483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*